- Does Premarin Vaginal Cream (conjugated estrogens) cause side effects?
- What are the important side effects of Premarin Vaginal Cream (conjugated estrogens)?
- Premarin Vaginal Cream (conjugated estrogens) side effects list for healthcare professionals
- What drugs interact with Premarin Vaginal Cream (conjugated estrogens)?
Does Premarin Vaginal Cream (conjugated estrogens) cause side effects?
Premarin Vaginal Cream (conjugated estrogens) is a mixture of several different estrogens (estrogen salts) that are derived from natural sources and blended to approximate the composition of estrogens in the urine of pregnant horses used to relieve vaginal symptoms in postmenopausal women who have vaginal dryness, inflammation, or painful intercourse due to atrophy of the vagina and vulva.
The main components are sodium estrone sulphate and sodium equilin sulfate. Estrogens have widespread effects on tissues in the body. Estrogens cause growth and development of the female sexual organs and maintain female sexual characteristics such as the growth of underarm and pubic hair, body contours, and skeleton. Estrogens also increase secretions from the cervix and growth of the inner lining of the uterus (endometrium).
Common side effects of Premarin Vaginal Cream include
- breakthrough bleeding or spotting,
- loss of periods,
- excessively prolonged periods,
- breast pain,
- breast enlargement, and
- changes in sex drive.
Serious side effects of Premarin Vaginal Cream include
- gallstones, hepatitis, migraine headaches, fluid retention (swelling of the lower legs), melasma (tan or brown patches) on the forehead, cheeks, or temples;
- an increased risk of breast cancer, blood clots, and stroke; and
- increased risk of impaired cognition and/or dementia among women over age 65.
Premarin Vaginal Cream drug interaction studies have not been conducted. Estrogens are broken down in the liver by certain enzymes. Drugs that increase or decrease the activity of these enzymes may interfere with the action of Premarin Vaginal Cream drug.
- Rifampin, barbiturates, carbamazepine, griseofulvin, phenytoin, St. John's wort, and primidone may increase the elimination of estrogen by enhancing the liver's ability to eliminate estrogens. Use of any of these medications with Premarin Vaginal Cream drug may result in a reduction of the beneficial effects of estrogens.
- Conversely, drugs such as erythromycin, ketoconazole, itraconazole, and ritonavir may reduce the elimination of estrogens by the liver and lead to increased levels of estrogens in the blood and increased effects.
- Grapefruit juice also may increase levels of estrogen by increasing the absorption of estrogens from the intestine. Increased levels of estrogens in the blood may result in more estrogen-related side effects.
Premarin Vaginal Cream drug should be avoided during pregnancy since they increase the risk of fetal abnormalities. Estrogens are secreted in milk and cause unpredictable effects in the infant. In general, Premarin Vaginal Cream should not be used by women who are breastfeeding.
What are the important side effects of Premarin Vaginal Cream (conjugated estrogens)?
Among the most common endocrine side effects are:
- breakthrough vaginal bleeding
- loss of periods,
- excessively prolonged periods,
- breast pain or
- breast enlargement, and
- changes in sexuality (increases or decreases in libido).
Other important side effects include:
- gallstones, and the gallstones may result in abdominal pain and require surgery.
- Migraine headaches, and
- retention of water (edema).
Melasma--tan or brown patches--may develop on the forehead, cheeks, or temples. These may persist even after the estrogen is stopped.
Conjugated estrogens may increase the curvature of the cornea, and patients with contact lenses may develop intolerance to their lenses.
Blood clots are an occasional, serious side effect of estrogen therapy and are dose-related. (The higher the dose of estrogen, the greater the risk of blood clots.) Cigarette smokers are at a higher risk than non-smokers for blood clots, and patients requiring estrogens should be encouraged to quit smoking.
Estrogens can promote thickening of the lining of the uterus (endometrial hyperplasia) and increase the risk of uterine cancer. At diagnosis, endometrial cancers in recipients of estrogens are generally at an earlier stage and are less aggressive when they are discovered. Survival from endometrial cancer also is better in women taking estrogens than in those not taking estrogens.
The addition of a progestin to estrogen therapy offsets the risk of endometrial cancer. Conflicting data exists on the association between estrogens and breast cancer. There may be a small increase in risk. The effect of concomitant progestin therapy on the risk of estrogen-induced breast cancer is unclear. Conjugated estrogens are well-absorbed from the vagina and into the blood. The amount absorbed depends on the frequency of use and the amount used.
Thus, more frequent use or larger amounts of vaginal estrogens can have effects throughout the body (see conjugated estrogens, Premarin). The Women's Health Initiative found that postmenopausal women (50-79 years old) taking conjugated estrogens had an increased risk of breast cancer, blood clots, and stroke. There was also an increased risk of impaired cognition and/or dementia among women over age 65.
Premarin Vaginal Cream (conjugated estrogens) side effects list for healthcare professionals
The following serious adverse reactions are discussed elsewhere in labeling:
- Cardiovascular Disorders
- Malignant Neoplasms
Clinical Study Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
During the first year of a 2-year clinical trial with 2,333 postmenopausal women with a uterus between 40 and 65 years of age (88 percent Caucasian), 1,012 women were treated with conjugated estrogens, and 332 were treated with placebo.
Table 1 summarizes treatment-related adverse reactions that occurred at a rate of ≥ 1 percent in any treatment group.
Table 1: TREATMENT RELATED ADVERSE REACTIONS AT A FREQUENCY ≥ 1 PERCENT
|PREMARIN0.625 mg (n=348)||PREMARIN0.45 mg (n=338)||PREMARIN0.3 mg (n=326)||Placebo (n=332)|
|Body as a whole|
|Abdominal pain||38 (11)||28 (8)||30 (9)||21 (6)|
|Asthenia||16 (5)||8 (2)||14 (4)||3 (1)|
|Back pain||18 (5)||11 (3)||13 (4)||4 (1)|
|Chest pain||2 (1)||3 (1)||4 (1)||2 (1)|
|Generalized edema||7 (2)||6 (2)||4 (1)||8 (2)|
|Headache||45 (13)||47 (14)||44 (13)||46 (14)|
|Moniliasis||5 (1)||4 (1)||4 (1)||1 (0)|
|Pain||17 (5)||10 (3)||12 (4)||14 (4)|
|Pelvic pain||10 (3)||9 (3)||8 (2)||4 (1)|
|Hypertension||4 (1)||4 (1)||7 (2)||5 (2)|
|Migraine||7 (2)||1 (0)||0||3 (1)|
|Palpitation||3 (1)||3 (1)||3 (1)||4 (1)|
|Vasodilatation||2 (1)||2 (1)||3 (1)||5 (2)|
|Constipation||7 (2)||6 (2)||4 (1)||3 (1)|
|Diarrhea||4 (1)||5 (1)||5 (2)||8 (2)|
|Dyspepsia||7 (2)||5 (1)||6 (2)||14 (4)|
|Eructation||1 (0)||1 (0)||4 (1)||1 (0)|
|Flatulence||22 (6)||18 (5)||13 (4)||8 (2)|
|Increased appetite||4 (1)||1 (0)||1 (0)||2 (1)|
|Nausea||16 (5)||10 (3)||15 (5)||16 (5)|
|Metabolic and nutritional|
|Hyperlipidemia||2 (1)||4 (1)||3 (1)||2 (1)|
|Peripheral edema||5 (1)||2 (1)||4 (1)||3 (1)|
|Weight gain||11 (3)||10 (3)||8 (2)||14 (4)|
|Arthralgia||6 (2)||3 (1)||2 (1)||5 (2)|
|Leg cramps||10 (3)||5 (1)||9 (3)||4 (1)|
|Myalgia||2 (1)||1 (0)||4 (1)||1 (0)|
|Anxiety||6 (2)||4 (1)||2 (1)||4 (1)|
|Depression||17 (5)||15 (4)||10 (3)||17 (5)|
|Dizziness||9 (3)||7 (2)||4 (1)||5 (2)|
|Emotional lability||3 (1)||4 (1)||5 (2)||8 (2)|
|Hypertonia||1 (0)||1 (0)||5 (2)||3 (1)|
|Insomnia||16 (5)||10 (3)||13 (4)||14 (4)|
|Nervousness||9 (3)||12 (4)||2 (1)||6 (2)|
|Skin and appendages|
|Acne||3 (1)||1 (0)||8 (2)||3 (1)|
|Alopecia||6 (2)||6 (2)||5 (2)||2 (1)|
|Hirsutism||4 (1)||2 (1)||1 (0)||0|
|Pruritus||11 (3)||11 (3)||10 (3)||3 (1)|
|Rash||6 (2)||3 (1)||1 (0)||2 (1)|
|Skin discoloration||4 (1)||2 (1)||0||1 (0)|
|Sweating||4 (1)||1 (0)||3 (1)||4 (1)|
|Breast disorder||6 (2)||3 (1)||3 (1)||6 (2)|
|Breast enlargement||3 (1)||4 (1)||7 (2)||3 (1)|
|Breast neoplasm||4 (1)||4 (1)||7 (2)||7 (2)|
|Breast pain||37 (11)||39 (12)||24 (7)||26 (8)|
|Cervix disorder||8 (2)||4 (1)||5 (2)||0|
|Dysmenorrhea||12 (3)||10 (3)||4 (1)||2 (1)|
|Endometrial disorder||4 (1)||2 (1)||2 (1)||0|
|Endometrial hyperplasia||16 (5)||8 (2)||1 (0)||0|
|Leukorrhea||17 (5)||17 (5)||12 (4)||6 (2)|
|Metrorrhagia||11 (3)||4 (1)||3 (1)||1 (0)|
|Urinary tract infection||1 (0)||2 (1)||1 (0)||4 (1)|
|Uterine fibroids enlarged||6 (2)||1 (0)||2 (1)||2 (1)|
|Uterine spasm||11 (3)||5 (1)||3 (1)||2 (1)|
|Vaginal dryness||1 (0)||2 (1)||1 (0)||6 (2)|
|Vaginal hemorrhage||46 (13)||13 (4)||6 (2)||0|
|Vaginal moniliasis||14 (4)||10 (3)||12 (4)||5 (2)|
|Vaginitis||18 (5)||7 (2)||9 (3)||1 (0)|
The following additional adverse reactions have been identified during post-approval use of Premarin. Because these reactions are reported voluntarily from a population of uncertain size, it is not possible always to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Abnormal uterine bleeding;
- dysmenorrheal or pelvic pain,
- increase in size of uterine leiomyomata,
- vaginitis, including vaginal candidiasis,
- change in cervical secretion,
- ovarian cancer,
- endometrial hyperplasia,
- endometrial cancer,
- fibrocystic breast changes,
- breast cancer,
- gynecomastia in males.
- Deep and superficial venous thrombosis,
- pulmonary embolism,
- myocardial infarction,
- increase in blood pressure.
- abdominal pain,
- cholestatic jaundice,
- increased incidence of gallbladder disease,
- enlargement of hepatic hemangiomas,
- ischemic colitis.
- Chloasma or melasma that may persist when drug is discontinued,
- erythema multiforme,
- erythema nodosum,
- loss of scalp hair,
- Retinal vascular thrombosis,
- intolerance to contact lenses.
Central nervous system
- mental depression,
- mood disturbances,
- exacerbation of epilepsy,
- possible growth potentiation of benign meningioma.
What drugs interact with Premarin Vaginal Cream (conjugated estrogens)?
- Data from a single-dose drug-drug interaction study involving conjugated estrogens and medroxyprogesterone acetate indicate that the pharmacokinetic disposition of both drugs is not altered when the drugs are coadministered. No other clinical drug-drug interaction studies have been conducted with conjugated estrogens.
- In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4).
- Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers of CYP3A4, such as St. John's Wort (Hypericum perforatum) preparations, phenobarbital, carbamazepine, and rifampin, may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile.
- Inhibitors of CYP3A4, such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice, may increase plasma concentrations of estrogens and may result in side effects.
Multimedia: Slideshows, Images & Quizzes
Menopause & Perimenopause: Symptoms, Signs
What is menopause? What are the signs of menopause? What age does menopause start? Learn about menopause and perimenopause...
Women's Health: 10 Tips to Ease Menopause Symptoms
What happens during menopause? At what age do menopause symptoms start? Women in their 40s or 50s may begin to have hot flashes,...
9 Signs of Perimenopause
Perimenopause occurs before menopause as estrogen levels begin to change. This can cause menopause like symptoms such as hot...
Menopause Quiz: Symptoms & Signs
The Menopause Quiz challenges your knowledge about the time in a woman’s life when menstruation ceases. Menopause can bring many...
Related Disease Conditions
What Happens During Menopause?
Menopause is the time in a woman's life when menstrual periods permanently stop, also called the "change of life." Menopause symptoms and signs include hot flashes, night sweats, irregular vaginal bleeding, vaginal dryness, painful intercourse, urinary incontinence, weight gain, and emotional symptoms such as mood swings. Treatment of menopausal symptoms varies, and should be discussed with your physician.
Perimenopause is the time in a woman's life when she is approaching menopause. During this time a woman starts to develop symptoms of declining estrogen levels that may include mood swings, painful sex, night sweats, hot flashes, and weight gain. Every adult woman eventually will experience perimenopause.
Premature menopause is when menopause occurs in a woman before the age of 40. Causes of premature menopause include premature ovarian failure, treatments for cancer and other conditions, surgical removal of the ovaries, or chronic diseases of the pituitary or thyroid gland, or psychiatric disorders. Treatment is directed at menopausal symptoms.
Sex and Menopause
How Long Does Menopause Last?
Some symptoms of menopause such as hot flashes (a sudden feeling of warmth in the upper part of the body) usually last for one to two years. However, they can continue for 10 years or longer.
Sex and Menopause (What to Expect)
Menopause is often associated with a change in sexual functioning. Loss of estrogen, bladder control issues, anxiety, stress, health concerns, medications, and sleep disturbances often result in a decrease in libido. Though there are currently no good drugs for treating sexual problems in women, there are ways to increase intimacy with a partner and treat vaginal dryness.
What Are the 40 Symptoms of Menopause?
Menopause is the end of the reproductive era of a woman’s life that is characterized by drastic changes in her emotional and physical aspects. Studies have identified around 40 signs and symptoms of menopause, but not every woman gets all of them.
Male menopause refers to the decline in testosterone production in men. As men age, they often experience many of the same symptoms that women experience in menopause. Testosterone replacement therapy may relieve some of these symptoms.
15 Things Women Should Know About Menopause
Menopause is a phase in a woman’s life that challenges her physically and emotionally. Many women deal with menopause without any medical treatments, whereas some women with severe symptoms require therapies.
8 Causes of Night Sweats: Menopause and More
Night sweats are episodes of excessive perspiration that happen during sleep. They are often described as soaking or drenching and may require a change of sheets or even clothes. Night sweats can occur during sleep and without physical exertion. They aren’t caused by a heavy blanket or a warm bedroom. Instead, other underlying health issues may be responsible for these episodes of considerable sweating during sleep.
Decreased Response and Pleasure: Sexual Side Effects of Menopause
Menopause marks the end of the reproductive era in a woman’s life. Some women view it positively as periods no longer trouble them and there is no chance of getting pregnant even with unprotected sex. However, as the estrogen and testosterone levels take a plunge during menopause, some women experience the sexual side effects of menopause.
Treatment & Diagnosis
- Perimenopause: Signs of Change: Perimenopause -- Laura Corio, MD -- 02/20/03
- Male Menopause
- Menopause: Super Nutrition for Menopause
- Menopause and Perimenopause, A Woman's Guide to
- Menopause: The Men's Guide to Understanding It
- Menopause: Making it the Best Years of Your Life
- Menopause: A New Perspective
- Menopause: Change of Life, Change of Diet
- Menopause Made Easy with Carolle Jean-Murat
- Menopause: Taking Charge
- Hormone Therapy After Menopause -- Susan Love, MD
- Menopause FAQs
- Thyroid Disease and Menopause
- The Women's Health Initiative in Perspective: The Last Straw for Estrogen Therapy?
- Menopause: Home Menopause Test Kits, Are They Worth It?
- Hot Flashes: Anxiety Worsens Hot Flashes
- Can Menopause Cause High Cholesterol?
- How Is Menopause Diagnosed After a Hysterectomy?
- How Does Menopause Affect Polycystic Ovarian Syndrome (PCOS)?
- Does Vaginal Moisture Change During Perimenopause?
- Do Soy Isoflavones Treat Menopause Hot Flashes?
- Can You Go Through Menopause at 40?
- Does Perimenopause Cause Mood Swings?
- Does Menopause Cause Pain During Sex?
- Does Menopause Affect Memory?
- Are Night Sweats a Sign of Menopause?
- Can Soy Help Menopause Symptoms?
- Do I Need Birth Control After Menopause?
- Does Menopause Cause High Blood Pressure?
- Do You Get More UTIs During Menopause?
- Can You Still Get Menopause After Hysterectomy?
- Do All Women Get Menopause?
- Male Menopause
- Menopause: 10 Questions To Ask Your Doctor
- Menopause Symptoms
- Ask the Experts - Menopause
- Menopause: Change of Life, Change of Diet
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.